Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Angelini Pharma Österreich (formerly CSC Pharmaceuticals Handels) is the Austrian subsidiary of the international Italian pharmaceutical group Angelini Industries. Originally established in 1997 as CSC Pharmaceuticals Handels GmbH, the company focuses on the distribution, marketing, and commercialization of prescription (Rx) and over-the-counter (OTC) medicines across Austria and Central and Eastern Europe. Its core therapeutic areas include brain health (psychiatry and neurology), pain relief, inflammation, and consumer healthcare. Key products in its commercial portfolio include the antidepressant Trittico (trazodone) and the anti-inflammatory sore throat treatment Tantum Verde (benzydamine). The company also partners with international biotech firms to commercialize specialty therapeutics, such as the oncology drug Iclusig (ponatinib) in regional markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CSC Pharmaceuticals Handels.